Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Human fibrinogen concentrate - LFB Biomedicaments

Next Previous
Search
Drug Profile

Human fibrinogen concentrate - LFB Biomedicaments

Alternative Names: Clottafact; FGTW; FibCLOT; Fibriclotte; Fibrinogen - LFB Biomedicaments

Latest Information Update: 17 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LFB Biomedicaments
  • Class Acute-phase proteins; Antihaemorrhagics; Blood coagulation factors; Blood proteins; Coagulants
  • Mechanism of Action Fibrinogen replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Afibrinogenaemia; Blood coagulation disorders
  • Phase III Surgical blood loss

Most Recent Events

  • 04 Oct 2022 Phase-III clinical trials in Surgical blood loss (In adults, In the elderly) in Italy, Germany, Spain (IV) (EudraCT2022-001759-17)
  • 04 Oct 2022 Phase-III clinical trials in Surgical blood loss (In adults, In the elderly) in Sweden (IV) (EudraCT2022-001759-17)
  • 25 Jul 2022 Launched for Afibrinogenaemia in Spain (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top